Skip to main content
Have a personal or library account? Click to login
Radiotherapy in palliative treatment of painful bone metastases Cover

Radiotherapy in palliative treatment of painful bone metastases

Radiology and Oncology
Volume 43 (2009): Issue 4 (December 2009)
By: ,   and    
Open Access
|Nov 2009
References

References

  1. Nielsen OS, Munro AJ, Tannock IF. Bone metastases: Pathophysiology and management policy.1991; 9: 509-24.
    Open DOISearch in Google Scholar
  2. Cleeland CS. Cancer-related symptoms.2000; 10: 175-90.
    Open DOISearch in Google Scholar
  3. Coleman RE. Bisphosphonates: clinical experience.2004; 9(Suppl 4): 14-27.
    Open DOISearch in Google Scholar
  4. Avazpour I, Roslan RE, Bayat P, Saripan MI, Nordin AJ, Raja Abdullah RSA. Segmenting CT images of bronchogenic carcinoma with bone metastases using PET intensity markers approach.2009; 43: 180-6.
    Open DOISearch in Google Scholar
  5. Stoll BA. Natural history, prognosis, and staging of bone metastases. In: Szoll BA, Parboo S, editors.New York: Raven; 1983. p. 1-20.
    Search in Google Scholar
  6. Chow E, Finkelstein JA, Coleman RE. Metastatic cancer to the bone. In: De Vita VT Jr, Hellman S, Rosenberg SA, editors.Vol 2. 8th edition. Philadelphia: Wolters Kluver, Lippincott; 2008. p. 2510-22.
    Search in Google Scholar
  7. Debevec L, Debeljak A, Eržen J, Kovač V, Kern I. Characterization of lung cancer patients, their actual treatment and survival: experience in Slovenia.2005; 39: 115-21.
    Search in Google Scholar
  8. Lote K, Walloe A, Bjersand A. Bone metastasis. Prognosis, diagnosis and treatment.1986; 25: 227-32.
    Open DOISearch in Google Scholar
  9. Rajer M, Kovač V. Malignant spinal cord compression.2008; 42: 23-31.
    Open DOISearch in Google Scholar
  10. Debois JM.Dordrecht: Kluwer Academic Publishers; 2002.
    Search in Google Scholar
  11. Jacobs SC. Spread of prostatic cancer to bone.1983; 21: 337-44.
    Open DOISearch in Google Scholar
  12. Mercadante S. Malignant bone pain: pathophysiology and treatment.1997; 69: 1-18.
    Open DOISearch in Google Scholar
  13. Strojan P, Debevec M, Kovač V. Superior sulcus tumor (SST): management at the Institute of Oncology in Ljubljana, Slovenia, 1981-1994.1997; 17: 249-59.
    Open DOISearch in Google Scholar
  14. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics an impact in patients with cancer pain.1999; 81: 129-34.
    Open DOISearch in Google Scholar
  15. Zucali R. Radiotherapy of bone lesions. In: Gerattini S, editor.New York: Raven; 1985. p. 117-26.
    Search in Google Scholar
  16. Pandit-Taskar N, Batraki M, Divgi CR. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.2004; 45: 1358-65.
    Search in Google Scholar
  17. Mercadante S, Fulfaro F. Management of painful bone metastases.2007; 19: 308-14.
    Open DOISearch in Google Scholar
  18. Dy SM, Asch SM, Naeim A, Sanati H, Walling A, Lorenz KA. Evidence-based standards for cancer pain management.2008; 26: 3879-85.
    Open DOISearch in Google Scholar
  19. Hoskin PJ. Opioids in context: relieving the pain of cancer. The role of comprehensive cancer management.2008; 22: 303-9.
    Open DOISearch in Google Scholar
  20. Vakaet LA, Boterberg T. Pain control by ionizing radiation of bone matastasis.2004; 48: 599-606.
    Open DOISearch in Google Scholar
  21. Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of randomised trials.2003; 15: 345-52.
    Open DOISearch in Google Scholar
  22. Wu JS, Wong R, Johnston M, Bezjak A, Whelan T; Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group. Meta-analysis of dosefractionation radiotherapy trials for the palliation of painful bone metastases.2003; 55: 594-605.
    Open DOISearch in Google Scholar
  23. Loblaw DA, Wu JS, Kirkbride P, Panzarella T, Smith K, Aslanidis J, et al. Pain flare in patients with bone metastases after palliative radiotherapy-a nested randomized control trial.2007; 15: 451-5.
    Open DOISearch in Google Scholar
  24. Hird A, Chow E, Zhang L, Wong R, Wu J, Sinclair E, et al. Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers.2009; 75: 193-7.
    Open DOISearch in Google Scholar
  25. Bone Pain Trial Working Party. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction shedule over 12 months of patients follow- up.1999; 52: 111-21.
    Open DOISearch in Google Scholar
  26. Foro Arnalot P, Fontanals AV, Galcerán JC, Lynd F, Latiesas XS, de Dios NR, et al. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction.2008; 89: 150-5.
    Open DOISearch in Google Scholar
  27. Gaze MN, Kelly CG, Kerr GR, Cull A, Cowie VJ, Gregor A, et al. Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules.1997; 45: 109-16.
    Open DOISearch in Google Scholar
  28. Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M 3rd, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M. Randomized trial of shortversus long-course radiotherapy for palliation of painful bone metastases.2005; 97: 798-804.
    Open DOISearch in Google Scholar
  29. Hirokawa Y, Wadasaki K, Kashiwado K, Kagemoto M, Katsuta S, Honke Y, et al. A multi-institutional prospective randomized study of radiation therapy of bone metastases.1988; 48: 1425-31.
    Search in Google Scholar
  30. Hoskin PJ, Price P, Easton D, Regan J, Austin D, Palmer S, et al. A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain.1992; 23: 74-8.
    Open DOISearch in Google Scholar
  31. Jeremic B, Shibamoto Y, Acimovic L, Milicic B, Milisavljevic S, Nikolic N, et al. A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain.1998; 42: 161-7.
    Open DOISearch in Google Scholar
  32. Kaasa S, Brenne E, Lund JA, Fayers P, Falkmer U, Holmberg M, et al. Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases.2006; 79: 278-84.
    Open DOISearch in Google Scholar
  33. Kirkbride P, Warde PR, Panzarella T, Aslanidis J, McKenzie M, Sun A. A Randomised trial comparing the efficacy of a single radiation fraction with fractionated radiation therapy in the palliation of skeletal metastases.2000; 48(Suppl 3): 185.
    Open DOISearch in Google Scholar
  34. Koswig S, Budach V. Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study.1999; 175: 500-8.
    Open DOISearch in Google Scholar
  35. Mañas A, Casas F, Ciria JP, López C, Sáez J, Palacios A, et al. Randomised study of single dose (8 Gy vs. 6 Gy) of analgesic radiotherapy plus zoledronic acid in patients with bone metastases.2008; 10: 281-7.
    Open DOISearch in Google Scholar
  36. Nielsen OS, Bentzen SM, Sandberg E, Gadeberg CC, Timothy AR. Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases.1998; 47: 233-40.
    Open DOISearch in Google Scholar
  37. Price P, Hoskin PJ, Easton D, Austin D, Palmer SG, Yarnold JR. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases.1986; 6: 247-55.
    Open DOISearch in Google Scholar
  38. Roos DE, Turner SL, O'Brien PC, Smith JG, Spry NA, Burmeister BH, et al, Trans-Tasman Radiation Oncology Group, TROG 96.05. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05).2005; 75: 54-63.
    Open DOISearch in Google Scholar
  39. Quilty PM, Kirk D, Bolger JJ, Dearnaley DP, Lewington VJ, Mason MD, et al. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer.1994; 31: 33-40.
    Open DOISearch in Google Scholar
  40. Rasmusson B, Vejborg I, Jensen AB, Andersson M, Banning AM, Hoffmann T, et al. Irradiation of bone metastases in breast cancer patients: a randomized study with 1 year follow-up.1995; 34: 179-84.
    Open DOISearch in Google Scholar
  41. Steenland E, Leer JW, van Houwelingen H, Post Wj, van den Hout WB, Kievit J, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study.1999; 52: 101-9.
    Open DOISearch in Google Scholar
  42. Tong D, Gillick, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group.1982; 50: 893-9.
    Open DOISearch in Google Scholar
  43. Chow E, Lutz S, Beyene J. A single fraction for all, or an argument for fractionation tailored to fit the needs of each individual patient with bone metastases.2003; 55: 565-7.
    Open DOISearch in Google Scholar
  44. Kovač V, Smrdel U. Meta-analyses of clinical trials in patients with non-small cell lung cancer.2004; 51: 334-40.
    Search in Google Scholar
  45. Jeremic B, Shibamoto Y, Igrutovic I. Single 4 Gy reirradiation for painful bone metastasis following single fraction radiotherapy.1999; 52: 123-7.
    Open DOISearch in Google Scholar
  46. Stanković M, Marić D, Ilić M, Veselinović I, Ninković S, Sečen S. Abscess of C1/C2 cervical vertebrae - errors in diagnosis and therapy.2009; 43: 240-6.
    Open DOISearch in Google Scholar
  47. Haddad P, Wong RK, Pond GR, Soban F, Williams D, McLean M, et al. Factors influencing the use of single vs multiple fractions of palliative radiotherapy for bone metastases: a 5-year review.2005; 17: 430-4.
    Open DOISearch in Google Scholar
  48. van den Hout WB, van der Linden YM, Steenland E, Wiggenraad RG, Kievit J, de Haes H, et al. Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial.2003; 95: 222-9.
    Open DOISearch in Google Scholar
  49. Pollicino CA, Turner SL, Roos DE, O'Brien PC. Costing the components of pain management: analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): one versus five fractions for neuropathic bone pain.2005; 76: 264-9.
    Open DOISearch in Google Scholar
  50. Salazar OM, Rubin P, Keller B, Scarantino C. Systemic (half-body) radiation therapy: Response and toxicity.1978; 4: 937-50.
    Open DOISearch in Google Scholar
  51. Salazar OM, Sandhu T, da Motta NW, Perez Escutia MA, Lanzos-Gonzales E, Mouelle-Sone A, et al. Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: A randomized phase III trial of the International Atomic Energy Agency (IAEA).2001; 50: 765-75.
    Open DOISearch in Google Scholar
  52. Salazar OM, Rubin P, Hendrickson FR, Komaki R, Poulter C, Newall J, et al. Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report.1986; 58: 29-36.
    Open DOISearch in Google Scholar
  53. Salazar OM, daMotta NW, Bridgman SM, Cardiges NM, Slawson RG. Fractionated half-body irradiation for pain palliation in widely metastatic cancers: Comparison with single dose.1996; 36: 49-60.
    Open DOISearch in Google Scholar
  54. Lewington VJ. Bone-seeking radionuclides for therapy.2005; 46: 38-47.
    Search in Google Scholar
  55. Porter AT, McEwan AJ, Powe JE, Reid R, McGowan DG, Lukka H, et al. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.1993; 25: 805-13.
    Open DOISearch in Google Scholar
  56. Piffanelli A, Dafermou A, Giganti M, Colamussi P, Pizzocaro C, Bestagno M, et al. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group.2001; 45: 100-7.
    Search in Google Scholar
  57. Roqué M, Martinez MJ, Alonso P, Catal E, Garcia JL, Ferrandiz M. Radioisotopes for metastatic bone pain.2003; 4: CD003347.
    Open DOISearch in Google Scholar
  58. Kampen WU, Fischer M. Pain palliation using unsealed radionuclides.2008; 22: 699-705.
    Search in Google Scholar
  59. Gkialas I, Iordanidou L, Galanakis I, Giannopoulos S. The use of radioisotopes for palliation of metastatic bone pain.2008; 13: 177-83.
    Search in Google Scholar
  60. Liberman B, Gianfelice D, Inbar Y, Beck A, Rabin T, Shabshin N, et al. Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study.2009; 16: 140-6.
    Open DOISearch in Google Scholar
  61. Tseng YY, Lo YL, Chen LH, Lai PL, Yang ST. Percutaneous polymethylmethacrylate vertebroplasty in the treatment of pain induced by metastatic spine tumor.2008; 70(Suppl 1): S78-83.
    Open DOISearch in Google Scholar
  62. Ross JR, Saunders Y, Edmonds PM, Patel S, Wonderling D, Normand C, et al. A systematic review of the role of bisphosphonates in metastatic disease.2004; 8: 1-176.
    Open DOISearch in Google Scholar
  63. Fleisch H. Development of bisphosphonates.2002; 4: 30-4.
    Open DOISearch in Google Scholar
  64. Boissier S, Ferreras M, Peyruchaud O, Magnetto S, Ebetino FH, Colombel M, et al. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.2000; 60: 2949-54.
    Search in Google Scholar
  65. Fromigue O, Lagneaux L, Body JJ. Bisphosphonates induce breast cancer cell death in vitro.2000; 15: 2211-21.
    Open DOISearch in Google Scholar
  66. Aapro M, Abrahamsson PA, Body JJ, Coleman RE, Colomer R, Costa L, et al. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.2008; 19: 420-32.
    Open DOISearch in Google Scholar
  67. Green JR, Muller K, Jaeggi KA: Preclinical pharmacology of CGP 42'446, a new potent, heterocyclic bisphosphonate compound.1994; 9: 745-51.
    Open DOISearch in Google Scholar
  68. Paterson AH, Powles TJ, Kanis JA, McCloskey E, Hanson J, Ashley S. Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.1993; 11: 59-65.
    Open DOISearch in Google Scholar
  69. Pavlakis N, Schmidt R, Stockler M. Bisphosphonates for breast cancer.2005; 3: CD003474.
    Open DOISearch in Google Scholar
  70. Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial.2003; 98: 1735-44.
    Open DOISearch in Google Scholar
  71. Neville-Webbe HL, Evans CA, Coleman RE, Holen I. Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro.2006; 27: 92-103.
    Open DOISearch in Google Scholar
  72. Vogt U, Bielawski KP, Bosse U, Schlotter CM. Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.2004; 12: 1109-14.
    Open DOISearch in Google Scholar
  73. Journé F, Magné N, Chaboteaux C, Kinnaert E, Bauss F, Body JJ. Sequence- and concentration-dependent effects of acute and long-term exposure to the bisphosphonate ibandronate in combination with single and multiple fractions of ionising radiation doses in human breast cancer cell lines.2006; 23: 135-47.
    Open DOISearch in Google Scholar
  74. Chang JW, Hsieh JJ, Shen YC, Yeh KY, Wang CH, Li YY, Hsu T. Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells.2009; 278: 17-26.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-009-0038-4 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 213 - 224
Published on: Nov 20, 2009
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
bone metastases,
palliative treatment,
radiotherapy
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2009 Andreja Horvat, Viljem Kovač, Primož Strojan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 43 (2009): Issue 4 (December 2009)
Next article